The John Wayne Cancer Institute (JWCI) at Saint John’s Health Center in Santa Monica, Calif. is a non-profit Institute that has received world-wide acclaim for its innovative research and treatments for complex cancer cases involving melanoma (skin cancer), breast, lung, colon, pancreatic and liver cancer, as well as lymphoma and leukemia. JWCI was formed in July of 1991 when a small group of scientists and physicians left UCLA Medical Center. A decade later, JWCI has pioneered some of the most advanced surgical techniques and research findings that has changed the way the medical profession and patients look at cancer.
Last year alone, patients traveled from 36 foreign countries and 48 states in the U.S. to be treated at JWCI. With its unique ability to rapidly turn scientific breakthroughs into innovative approaches to treatment and early detection, JWCI provides immediate hope to cancer patients from around the globe. Breast cancer patients are treated at one of the top 10 breast centers in the world, the Joyce Eisenberg Keefer Breast Center, which has been the pioneering force behind the adoption of the “sentinel blue node” technique, a revolutionary and less invasive surgical procedure to determine cancerous cells in lymph nodes. As part of the John Wayne Cancer Institute, the Joyce Eisenberg Keefer Breast Center is a complete and comprehensive breast center for treatment, prevention, psychosocial support, education and early detection research.
Miller Geer & Associates has worked closely with the John Wayne Cancer Institute for over a year with the purpose of publicizing clinical trials that can benefit cancer patients both here in the U.S. and broad. In working within guidelines set forth by the National Institutes of Health and the National Cancer Institute-sponsored clinical trials, MGA has aggressively pursued exposure for major multi-center clinical trials that include but are not limited to the following:
– Canvaxin™: Therapeutic Cancer Vaccine for Melanoma
– Sentinel Node Technique: Lymphatic Mapping for Detecting Spread of Melanoma, Breast and Colon Cancer.
To increase awareness about new research and treatments, MGA has coordinated with JWCI physicians and health officials to prepare accurate press materials detailing the information to be published in major medical journals across the country and around the world.
The result has been an estimated $6 million in exposure on local and national print, radio, television and the internet.